-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Efficacy of Brentuximab Vedotin Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma with and without Pre-Transplant Exposure to Novel Agents

Program: Special-Interest Sessions
Session: Promoting Minorities in Hematology (PMH) Oral Presentations: Room I (for in-person participants)
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Saturday, December 9, 2023, 6:30 PM-8:00 PM

Ayo S Falade, MD, MBA

Mass General Brigham Salem Hospital, Salem, MA

Disclosures: No relevant conflicts of interest to declare.

Previous Presentation | Next Presentation >>